7 3 chemotherapy
Showing 1 - 25 of >10,000
Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,
Not yet recruiting
- Acute Myeloid Leukemia
- +10 more
- Ziftomenib
- +4 more
- (no location specified)
Feb 17, 2023
Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Neoplasm
- Magrolimab
- +2 more
- (no location specified)
Apr 24, 2023
AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)
Recruiting
- AML, Adult
- Chemotherapy Effect
- Venetoclax
- +3 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 28, 2022
Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,
Recruiting
- Gastric Adenocarcinoma
- +4 more
- Capecitabine
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 20, 2022
Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)
Not yet recruiting
- Localized Osteosarcoma
- +3 more
- Cabozantinib S-malate
- +7 more
- (no location specified)
Jan 4, 2023
NSCLC Trial in Canada (Osimertinib First-Line, Platinum + Pemetrexed Chemotherapy Second-Line, Osimertinib Third-Line)
Recruiting
- Non-Small Cell Lung Cancer
- Osimertinib First-Line
- +2 more
-
Vancouver, British Columbia, Canada
- +9 more
Jun 21, 2022
Diffuse Large B Cell Lymphoma Trial (Pembrolizumab, Rituximab, Ifosfamide)
Recruiting
- Diffuse Large B Cell Lymphoma
- Pembrolizumab
- +4 more
-
Headington, Oxford, United Kingdom
- +1 more
Nov 2, 2022
Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,
Not yet recruiting
- Metastatic Colorectal Carcinoma
- +3 more
- Bevacizumab
- +11 more
- (no location specified)
May 9, 2023
Metastatic NSCLC Trial in Worldwide (Volrustomig, Pembrolizumab, Carboplatin)
Not yet recruiting
- Metastatic Non-small Cell Lung Cancer
- Volrustomig
- +4 more
-
Rosario, Argentina
- +51 more
Aug 2, 2023
Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)
Recruiting
- Newly Diagnosed Acute Myeloid Leukemia (AML)
- SKLB1028 Dose Escalation
-
Chengdu, ChinaWest China Hospital of Sichuan University
Jun 30, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +12 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jun 16, 2022
Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in
Completed
- Stage III Cutaneous Melanoma AJCC v7
- +5 more
- Aldesleukin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2022
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage II Breast Cancer AJCC v8
- +3 more
- Biospecimen Collection
- +7 more
-
Portland, OregonSWOG
Sep 27, 2023
Ovarian Cancer Trial in United Kingdom (Olaparib, Cediranib, Paclitaxel)
Active, not recruiting
- Ovarian Cancer
- Olaparib
- +2 more
-
Belfast, County Antrim, United Kingdom
- +13 more
Feb 22, 2022
Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Canada, United States (Nemvaleukin
Recruiting
- Platinum-resistant Ovarian Cancer
- +2 more
- Nemvaleukin and Pembrolizumab Combination
- +6 more
-
Ventura, California
- +7 more
Aug 5, 2022
Acute Myeloid Leukemia (AML) Trial in Worldwide (standard combination chemo, decitabine)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- standard combination chemotherapy
- decitabine
-
Edegem, Antwerpen, Belgium
- +52 more
Sep 13, 2022
Carcinosarcoma, Endometrial Tumors Trial in United Kingdom (Paclitaxel, Cediranib, Olaparib)
Active, not recruiting
- Carcinosarcoma
- Endometrial Neoplasms
- Paclitaxel
- +2 more
-
Northwood, Middlesex, United Kingdom
- +14 more
Feb 10, 2022
Disease State in Adult Acute Myeloid Leukemia Ineligible for
Not yet recruiting
- Acute Myeloid Leukemia
-
Calgary, Alberta, Canada
- +9 more
Jun 15, 2022
Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma Trial in United States (Laboratory
Active, not recruiting
- Metastatic Colon Carcinoma
- +24 more
- Laboratory Biomarker Analysis
- +2 more
-
Corona, California
- +7 more
Oct 26, 2022
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV, Pancreatic Cancer Non-resectable Trial in Oxford (Focused
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
- Focused Ultrasound
- +2 more
-
Oxford, United KingdomOxford University Hospitals NHS Trust
Feb 22, 2022
Colorectal Adenocarcinoma, Colorectal Carcinoma Metastatic in the Lung, Stage IV Colorectal Cancer AJCC v8 Trial in Canada,
Recruiting
- Colorectal Adenocarcinoma
- +5 more
- Chemotherapy
- Metastasectomy
-
Boston, Massachusetts
- +7 more
Apr 19, 2022
Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,
Completed
- Metastatic Melanoma
- +3 more
- Aldesleukin
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2022
Lung Cancer Metastatic Trial in Australia, Canada (Durvalumab, Tremelimumab, Platinum-Based Drug)
Active, not recruiting
- Lung Cancer Metastatic
- Durvalumab
- +2 more
-
Campbelltown, New South Wales, Australia
- +48 more
Jun 23, 2022